<DOC>
	<DOCNO>NCT01151683</DOCNO>
	<brief_summary>Introduction : Magnesium target many experimental clinical study due negative correlation serum intracellular level prevalence hypertension cardiovascular disease . Objective : To evaluate effect magnesium supplementation hypertensive patient diuretic treatment , include correlation clinical nutritional parameter structural functional aspect macrocirculation . Methods : A prospective , randomize , double blind , placebo control study perform hypertensive patient , age 40 65 years-old , regular use thiazidic diuretic antihypertensive monotherapy , . The patient divide two main group accord supplementation placebo magnesium chelate 300mg twice day ( total 600mg magnesium element per day ) . Before 3 6 month supplementation , patient submit clinical nutritional evaluation , biochemical analysis , include intracellular magnesium measurement , study macrocirculation ambulatory blood pressure monitoring , analysis flow-mediated dilation brachial artery , measurement carotid intima-media thickness , carotid-femoral carotid-radial pulse wave velocity estimate central peripheral arterial stiffness . Analysis : Data express mean±epm . Statistical analysis perform use software Prism® ( GraphPad , version 5.0 ) . Continuous variable group compare use `` test '' , P &lt; 0.05 consider statistically significant .</brief_summary>
	<brief_title>Effects Magnesium Supplementation Vascular Structure Function Hypertensive Patients</brief_title>
	<detailed_description>The main objective study evaluate whether magnesium supplementation associate improved blood pressure control whether beneficial effect vascular structure function non-diabetic hypertensive patient receive r diuretic therapy . Patients evaluate prospective , randomize , double-blind study admit study reach inclusion criterion exclusion criterion . In study , magnesium chelate choose good absorption rate . The dosage different many protocol project patient receive 600 mg magnesium element daily divide 300 mg twice day . The patient divide two main group accord supplementation placebo magnesium chelate 300mg twice day ( total 600mg magnesium element per day ) . Before 3 6 month supplementation , patient submit clinical nutritional evaluation , biochemical analysis , include intracellular magnesium measurement , study macrocirculation ambulatory blood pressure monitoring , analysis flow-mediated dilation brachial artery , measurement carotid intima-media thickness , carotid-femoral carotid-radial pulse wave velocity estimate central peripheral arterial stiffness .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Women age 40 65 yearsold Hypertension mild blood pressure elevation : Systolic BP 140 159mmHg AND/OR Diastolic BP 90 99 mmHg Antihypertensive monotherapy daily use thiazidic diuretic , least last 30 day Signature Informed Consent patient legal representative Evidences secondary hypertension Hypertension stage 2 , SBP ≥ 160mmHg and/or DBP ≥ 100mmHg , begin supplementation Blood pressure &gt; 180 x 100 mmHg phase study Body mass index &gt; 35 kg/m2 Diabetes Mellitus Renal disease present glomerular filtration rate &lt; 60ml/min Coronary artery disease clinically evident previous episode myocardial infarction and/or myocardial revascularization Clinical sign heart failure History stroke Any condition , disease therapy , investigator 's opinion , may influence objective , result , put risk safety patient . Pregnancy Patients take mineral vitamin supplement Gastrointestinal condition</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>hypertension</keyword>
	<keyword>endothelial dysfunction</keyword>
</DOC>